A Study to Compare Brachial Artery Reactivity and Cardiovascular Risk of a Treatment Simplification by Darunavir/Ritonavir (DRV/r) 800/100 mg Versus a Triple Combination Therapy Containing DRV/r in HIV-1 Infected Patients

Name: A Study to Compare Brachial Artery Reactivity and Cardiovascular Risk of a Treatment Simplification by Darunavir/Ritonavir (DRV/r) 800/100 mg Versus a Triple Combination Therapy Containing DRV/r in HIV-1 Infected Patients
Published: 2009
License: Public Domain

Janssen-Cilag S.p.A. · 2009

ClinicalTrials.gov · Datasets · License: Public Domain · 2009

Open Source ↗

acquired-immunodeficiency-syndrome

human immunodeficiency virus 1, acquired immunodeficiency syndrome, immunologic deficiency syndrome, darunavir/ritonavir, darunavir, ritonavir, nucleoside reverse transcriptase inhibitors (nrtis), prezista, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study to Compare Brachial Artery Reactivity and Cardiovascular Risk of a Treatment Simplification by Darunavir/Ritonavir (DRV/r) 800/100 mg Versus a Triple Combination Therapy Containing DRV/r in HIV-1 Infected Patients

Related documents